Table 2

Chemotherapy details

Chemotherapy details
VariableNo. (%) *
All cases127
Median no. of cyles of NACT (range)4 (3–8)
Type of chemotherapy
 Carboplatin – paclitaxol (either weekly or monthly)92 (72.4)
 Carboplatin – paclitaxol – bevacizumab27 (21.3)
 Other (platinum-based)8 (6.3)
Median Ca-125 serum level (range) at IDS, UI/ml32 (2–2122
RECIST response
 Complete38 (29.9)
 Partial85 (66.9)
 Stable4 (3.1)
Pathological response
 Complete27 (21.3)
 Partial100 (78.7)
  Partial micro†19 (24.7)
  • IDS, interval debulking surgery. RECIST, Response Evaluation Criteria in Solid Tumors.

  • *Results are presented as N (%) except where indicated.

  • †19 of 77 cases.